Rights and permissions
About this article
Cite this article
CHF DM programme prolongs survival but no cost savings. Pharmacoecon. Outcomes News 469, 11 (2005). https://doi.org/10.2165/00151234-200504690-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504690-00017